Global Opioid-Induced Constipation Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 20-Sep-2018
No. of pages: 137

Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation. Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation.

Scope of the Report:

This report focuses on the Opioid-Induced Constipation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The opioid analgesics produce analgesia by the activation of the mu receptors found in the CNS and PNS. These drugs affect the motility, tone, and contractility of the bowel functions, which results in the delay in the transit of fecal contents. The opioids also cause a reduction in the secretion of digestive enzymes and also cause partial gastroparesis. Some of the common symptoms of opioid-induced constipation are hard and dry stools, painful defecation, bloating, distention and bulged abdomen, feeling lethargic, and loss of appetite.

The worldwide market for Opioid-Induced Constipation is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- AstraZeneca

- Takeda Pharmaceutical

- Valeant Pharmaceuticals International

- Abbott

- Bayer

- Boehringer Ingelheim

- C.B. Fleet

- Cosmo Pharmaceuticals

- Daewoong

- Daiichi Sankyo

- GlaxoSmithKline

- Ironwood Pharmaceuticals

- Johnson & Johnson

- Merck

- Mundipharma

- Nektar Therapeutics

- Pfizer

- Progenics Pharmaceuticals

- Shionogi

- SLA Pharma

- Sucampo

- Synergy Pharmaceuticals

- Theravance

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Solid

- Liquid

Market Segment by Applications, can be divided into

- Drugstore

- Hospital

- Others

There are 15 Chapters to deeply display the global Opioid-Induced Constipation market.

Chapter 1, to describe Opioid-Induced Constipation Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Opioid-Induced Constipation, with sales, revenue, and price of Opioid-Induced Constipation, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Opioid-Induced Constipation, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Opioid-Induced Constipation market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Opioid-Induced Constipation sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Opioid-Induced Constipation Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents
1 Market Overview
1.1 Opioid-Induced Constipation Introduction
1.2 Market Analysis by Type
1.2.1 Solid
1.2.2 Liquid
1.3 Market Analysis by Applications
1.3.1 Drugstore
1.3.2 Hospital
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Opioid-Induced Constipation Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Takeda Pharmaceutical
2.2.1 Business Overview
2.2.2 Opioid-Induced Constipation Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Takeda Pharmaceutical Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Valeant Pharmaceuticals International
2.3.1 Business Overview
2.3.2 Opioid-Induced Constipation Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Valeant Pharmaceuticals International Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott
2.4.1 Business Overview
2.4.2 Opioid-Induced Constipation Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bayer
2.5.1 Business Overview
2.5.2 Opioid-Induced Constipation Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bayer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.2 Opioid-Induced Constipation Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boehringer Ingelheim Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 C.B. Fleet
2.7.1 Business Overview
2.7.2 Opioid-Induced Constipation Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 C.B. Fleet Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cosmo Pharmaceuticals
2.8.1 Business Overview
2.8.2 Opioid-Induced Constipation Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cosmo Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Daewoong
2.9.1 Business Overview
2.9.2 Opioid-Induced Constipation Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Daewoong Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Daiichi Sankyo
2.10.1 Business Overview
2.10.2 Opioid-Induced Constipation Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Daiichi Sankyo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 GlaxoSmithKline
2.11.1 Business Overview
2.11.2 Opioid-Induced Constipation Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GlaxoSmithKline Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Ironwood Pharmaceuticals
2.12.1 Business Overview
2.12.2 Opioid-Induced Constipation Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Ironwood Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Johnson & Johnson
2.13.1 Business Overview
2.13.2 Opioid-Induced Constipation Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Johnson & Johnson Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Merck
2.14.1 Business Overview
2.14.2 Opioid-Induced Constipation Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Merck Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Mundipharma
2.15.1 Business Overview
2.15.2 Opioid-Induced Constipation Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Mundipharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Nektar Therapeutics
2.16.1 Business Overview
2.16.2 Opioid-Induced Constipation Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Nektar Therapeutics Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Pfizer
2.17.1 Business Overview
2.17.2 Opioid-Induced Constipation Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Pfizer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Progenics Pharmaceuticals
2.18.1 Business Overview
2.18.2 Opioid-Induced Constipation Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Shionogi
2.19.1 Business Overview
2.19.2 Opioid-Induced Constipation Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Shionogi Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 SLA Pharma
2.20.1 Business Overview
2.20.2 Opioid-Induced Constipation Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 SLA Pharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Sucampo
2.21.1 Business Overview
2.2.2 Opioid-Induced Constipation Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Sucampo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Synergy Pharmaceuticals
2.22.1 Business Overview
2.22.2 Opioid-Induced Constipation Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Synergy Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.23 Theravance
2.23.1 Business Overview
2.23.2 Opioid-Induced Constipation Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Theravance Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Opioid-Induced Constipation Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Opioid-Induced Constipation Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Opioid-Induced Constipation Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Opioid-Induced Constipation Manufacturer Market Share in 2017
3.3.2 Top 6 Opioid-Induced Constipation Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Opioid-Induced Constipation Market Analysis by Regions
4.1 Global Opioid-Induced Constipation Sales, Revenue and Market Share by Regions
4.1.1 Global Opioid-Induced Constipation Sales and Market Share by Regions (2013-2018)
4.1.2 Global Opioid-Induced Constipation Revenue and Market Share by Regions (2013-2018)
4.2 North America Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
4.3 Europe Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
4.5 South America Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
5 North America Opioid-Induced Constipation by Countries
5.1 North America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
5.1.1 North America Opioid-Induced Constipation Sales and Market Share by Countries (2013-2018)
5.1.2 North America Opioid-Induced Constipation Revenue and Market Share by Countries (2013-2018)
5.2 United States Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
5.3 Canada Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
5.4 Mexico Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
6 Europe Opioid-Induced Constipation by Countries
6.1 Europe Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
6.1.1 Europe Opioid-Induced Constipation Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Opioid-Induced Constipation Revenue and Market Share by Countries (2013-2018)
6.2 Germany Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
6.3 UK Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
6.4 France Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
6.5 Russia Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
6.6 Italy Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
7 Asia-Pacific Opioid-Induced Constipation by Countries
7.1 Asia-Pacific Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Opioid-Induced Constipation Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Opioid-Induced Constipation Revenue and Market Share by Countries (2013-2018)
7.2 China Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
7.3 Japan Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
7.4 Korea Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
7.5 India Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
8 South America Opioid-Induced Constipation by Countries
8.1 South America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
8.1.1 South America Opioid-Induced Constipation Sales and Market Share by Countries (2013-2018)
8.1.2 South America Opioid-Induced Constipation Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
8.3 Argentina Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
8.4 Colombia Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
9 Middle East and Africa Opioid-Induced Constipation by Countries
9.1 Middle East and Africa Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Opioid-Induced Constipation Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Opioid-Induced Constipation Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
9.3 UAE Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
9.4 Egypt Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
9.5 Nigeria Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
9.6 South Africa Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
10 Global Opioid-Induced Constipation Market Segment by Type
10.1 Global Opioid-Induced Constipation Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Opioid-Induced Constipation Sales and Market Share by Type (2013-2018)
10.1.2 Global Opioid-Induced Constipation Revenue and Market Share by Type (2013-2018)
10.2 Solid Sales Growth and Price
10.2.1 Global Solid Sales Growth (2013-2018)
10.2.2 Global Solid Price (2013-2018)
10.3 Liquid Sales Growth and Price
10.3.1 Global Liquid Sales Growth (2013-2018)
10.3.2 Global Liquid Price (2013-2018)
11 Global Opioid-Induced Constipation Market Segment by Application
11.1 Global Opioid-Induced Constipation Sales Market Share by Application (2013-2018)
11.2 Drugstore Sales Growth (2013-2018)
11.3 Hospital Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Opioid-Induced Constipation Market Forecast (2018-2023)
12.1 Global Opioid-Induced Constipation Sales, Revenue and Growth Rate (2018-2023)
12.2 Opioid-Induced Constipation Market Forecast by Regions (2018-2023)
12.2.1 North America Opioid-Induced Constipation Market Forecast (2018-2023)
12.2.2 Europe Opioid-Induced Constipation Market Forecast (2018-2023)
12.2.3 Asia-Pacific Opioid-Induced Constipation Market Forecast (2018-2023)
12.2.4 South America Opioid-Induced Constipation Market Forecast (2018-2023)
12.2.5 Middle East and Africa Opioid-Induced Constipation Market Forecast (2018-2023)
12.3 Opioid-Induced Constipation Market Forecast by Type (2018-2023)
12.3.1 Global Opioid-Induced Constipation Sales Forecast by Type (2018-2023)
12.3.2 Global Opioid-Induced Constipation Market Share Forecast by Type (2018-2023)
12.4 Opioid-Induced Constipation Market Forecast by Application (2018-2023)
12.4.1 Global Opioid-Induced Constipation Sales Forecast by Application (2018-2023)
12.4.2 Global Opioid-Induced Constipation Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Opioid-Induced Constipation Picture
Table Product Specifications of Opioid-Induced Constipation
Figure Global Sales Market Share of Opioid-Induced Constipation by Types in 2017
Table Opioid-Induced Constipation Types for Major Manufacturers
Figure Solid Picture
Figure Liquid Picture
Figure Opioid-Induced Constipation Sales Market Share by Applications in 2017
Figure Drugstore Picture
Figure Hospital Picture
Figure Others Picture
Figure United States Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure France Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure UK Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure China Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure India Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Opioid-Induced Constipation Type and Applications
Table AstraZeneca Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Opioid-Induced Constipation Type and Applications
Table Takeda Pharmaceutical Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Pharmaceuticals International Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals International Opioid-Induced Constipation Type and Applications
Table Valeant Pharmaceuticals International Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Opioid-Induced Constipation Type and Applications
Table Abbott Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Opioid-Induced Constipation Type and Applications
Table Bayer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Opioid-Induced Constipation Type and Applications
Table Boehringer Ingelheim Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table C.B. Fleet Basic Information, Manufacturing Base and Competitors
Table C.B. Fleet Opioid-Induced Constipation Type and Applications
Table C.B. Fleet Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cosmo Pharmaceuticals Opioid-Induced Constipation Type and Applications
Table Cosmo Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Daewoong Basic Information, Manufacturing Base and Competitors
Table Daewoong Opioid-Induced Constipation Type and Applications
Table Daewoong Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Opioid-Induced Constipation Type and Applications
Table Daiichi Sankyo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Opioid-Induced Constipation Type and Applications
Table GlaxoSmithKline Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ironwood Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ironwood Pharmaceuticals Opioid-Induced Constipation Type and Applications
Table Ironwood Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Opioid-Induced Constipation Type and Applications
Table Johnson & Johnson Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Opioid-Induced Constipation Type and Applications
Table Merck Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mundipharma Basic Information, Manufacturing Base and Competitors
Table Mundipharma Opioid-Induced Constipation Type and Applications
Table Mundipharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table Nektar Therapeutics Opioid-Induced Constipation Type and Applications
Table Nektar Therapeutics Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Opioid-Induced Constipation Type and Applications
Table Pfizer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Progenics Pharmaceuticals Opioid-Induced Constipation Type and Applications
Table Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shionogi Basic Information, Manufacturing Base and Competitors
Table Shionogi Opioid-Induced Constipation Type and Applications
Table Shionogi Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SLA Pharma Basic Information, Manufacturing Base and Competitors
Table SLA Pharma Opioid-Induced Constipation Type and Applications
Table SLA Pharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sucampo Basic Information, Manufacturing Base and Competitors
Table Sucampo Opioid-Induced Constipation Type and Applications
Table Sucampo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synergy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Synergy Pharmaceuticals Opioid-Induced Constipation Type and Applications
Table Synergy Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Theravance Basic Information, Manufacturing Base and Competitors
Table Theravance Opioid-Induced Constipation Type and Applications
Table Theravance Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Opioid-Induced Constipation Sales by Manufacturer (2016-2017)
Figure Global Opioid-Induced Constipation Sales Market Share by Manufacturer in 2016
Figure Global Opioid-Induced Constipation Sales Market Share by Manufacturer in 2017
Table Global Opioid-Induced Constipation Revenue by Manufacturer (2016-2017)
Figure Global Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2016
Figure Global Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2017
Figure Top 3 Opioid-Induced Constipation Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Opioid-Induced Constipation Manufacturer (Revenue) Market Share in 2017
Figure Global Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Global Opioid-Induced Constipation Revenue and Growth Rate (2013-2018)
Table Global Opioid-Induced Constipation Sales by Regions (2013-2018)
Table Global Opioid-Induced Constipation Sales Market Share by Regions (2013-2018)
Table Global Opioid-Induced Constipation Revenue by Regions (2013-2018)
Figure Global Opioid-Induced Constipation Revenue Market Share by Regions in 2013
Figure Global Opioid-Induced Constipation Revenue Market Share by Regions in 2017
Figure North America Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Europe Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure South America Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure North America Opioid-Induced Constipation Revenue and Growth Rate (2013-2018)
Table North America Opioid-Induced Constipation Sales by Countries (2013-2018)
Table North America Opioid-Induced Constipation Sales Market Share by Countries (2013-2018)
Figure North America Opioid-Induced Constipation Sales Market Share by Countries in 2013
Figure North America Opioid-Induced Constipation Sales Market Share by Countries in 2017
Table North America Opioid-Induced Constipation Revenue by Countries (2013-2018)
Table North America Opioid-Induced Constipation Revenue Market Share by Countries (2013-2018)
Figure North America Opioid-Induced Constipation Revenue Market Share by Countries in 2013
Figure North America Opioid-Induced Constipation Revenue Market Share by Countries in 2017
Figure United States Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Canada Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Mexico Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Europe Opioid-Induced Constipation Revenue and Growth Rate (2013-2018)
Table Europe Opioid-Induced Constipation Sales by Countries (2013-2018)
Table Europe Opioid-Induced Constipation Sales Market Share by Countries (2013-2018)
Table Europe Opioid-Induced Constipation Revenue by Countries (2013-2018)
Figure Europe Opioid-Induced Constipation Revenue Market Share by Countries in 2016
Figure Europe Opioid-Induced Constipation Revenue Market Share by Countries in 2017
Figure Germany Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure UK Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure France Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Russia Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Italy Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Opioid-Induced Constipation Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Opioid-Induced Constipation Sales by Countries (2013-2018)
Table Asia-Pacific Opioid-Induced Constipation Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Opioid-Induced Constipation Sales Market Share by Countries 2017
Table Asia-Pacific Opioid-Induced Constipation Revenue by Countries (2013-2018)
Figure Asia-Pacific Opioid-Induced Constipation Revenue Market Share by Countries 2017
Figure China Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Japan Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Korea Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure India Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Southeast Asia Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure South America Opioid-Induced Constipation Revenue and Growth Rate (2013-2018)
Table South America Opioid-Induced Constipation Sales by Countries (2013-2018)
Table South America Opioid-Induced Constipation Sales Market Share by Countries (2013-2018)
Figure South America Opioid-Induced Constipation Sales Market Share by Countries in 2017
Table South America Opioid-Induced Constipation Revenue by Countries (2013-2018)
Table South America Opioid-Induced Constipation Revenue Market Share by Countries (2013-2018)
Figure South America Opioid-Induced Constipation Revenue Market Share by Countries in 2017
Figure Brazil Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Argentina Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Colombia Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Opioid-Induced Constipation Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Opioid-Induced Constipation Sales by Countries (2013-2018)
Table Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries in 2017
Table Middle East and Africa Opioid-Induced Constipation Revenue by Countries (2013-2018)
Table Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries in 2013
Figure Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries in 2017
Figure Saudi Arabia Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure UAE Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Egypt Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Nigeria Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure South Africa Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Table Global Opioid-Induced Constipation Sales by Type (2013-2018)
Table Global Opioid-Induced Constipation Sales Share by Type (2013-2018)
Table Global Opioid-Induced Constipation Revenue by Type (2013-2018)
Table Global Opioid-Induced Constipation Revenue Share by Type (2013-2018)
Figure Global Solid Sales Growth (2013-2018)
Figure Global Solid Price (2013-2018)
Figure Global Liquid Sales Growth (2013-2018)
Figure Global Liquid Price (2013-2018)
Table Global Opioid-Induced Constipation Sales by Application (2013-2018)
Table Global Opioid-Induced Constipation Sales Share by Application (2013-2018)
Figure Global Hospital Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Opioid-Induced Constipation Sales, Revenue and Growth Rate (2018-2023)
Table Global Opioid-Induced Constipation Sales Forecast by Regions (2018-2023)
Table Global Opioid-Induced Constipation Market Share Forecast by Regions (2018-2023)
Figure North America Sales Opioid-Induced Constipation Market Forecast (2018-2023)
Figure Europe Sales Opioid-Induced Constipation Market Forecast (2018-2023)
Figure Asia-Pacific Sales Opioid-Induced Constipation Market Forecast (2018-2023)
Figure South America Sales Opioid-Induced Constipation Market Forecast (2018-2023)
Figure Middle East and Africa Sales Opioid-Induced Constipation Market Forecast (2018-2023)
Table Global Opioid-Induced Constipation Sales Forecast by Type (2018-2023)
Table Global Opioid-Induced Constipation Market Share Forecast by Type (2018-2023)
Table Global Opioid-Induced Constipation Sales Forecast by Application (2018-2023)
Table Global Opioid-Induced Constipation Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Cholera Vaccines Market Insights, Forecast to 2025
    Published: 14-Dec-2018        Price: US 3900 Onwards        Pages: 112
    In 2017, the global Cholera Vaccines market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Cholera Vaccines market based on company, product type, application and key regions. This report studies the global market size of Cholera Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on th......
  • Global and Chinese Zika Virus Testing Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 149
    The 'Global and Chinese Zika Virus Testing Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Zika Virus Testing industry with a focus on the Chinese market. The report provides key statistics on the market status of the Zika Virus Testing manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including ......
  • Global and Chinese Human Rabies Immunoglobulin (IM) Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 141
    The 'Global and Chinese Human Rabies Immunoglobulin (IM) Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Human Rabies Immunoglobulin (IM) industry with a focus on the Chinese market. The report provides key statistics on the market status of the Human Rabies Immunoglobulin (IM) manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a......
  • Global and Chinese Antiemetics Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 145
    The 'Global and Chinese Antiemetics Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Antiemetics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Antiemetics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, appli......
  • Global and Chinese Botulinum Toxin Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 145
    The 'Global and Chinese Botulinum Toxin Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Botulinum Toxin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Botulinum Toxin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its defin......
  • Global Immunoglobulin Products Market Insights, Forecast to 2025
    Published: 14-Dec-2018        Price: US 3900 Onwards        Pages: 119
    In 2017, the global Immunoglobulin Products market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Immunoglobulin Products market based on company, product type, application and key regions. This report studies the global market size of Immunoglobulin Products in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & ......
  • Global Alpha-1 Antitrypsin Drugs Market Insights, Forecast to 2025
    Published: 14-Dec-2018        Price: US 3900 Onwards        Pages: 110
    In 2017, the global Alpha-1 Antitrypsin Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Alpha-1 Antitrypsin Drugs market based on company, product type, application and key regions. This report studies the global market size of Alpha-1 Antitrypsin Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle E......
  • Global and Chinese Atropine Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 149
    The 'Global and Chinese Atropine Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Atropine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Atropine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, applications a......
  • Global and Chinese Urokinase Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 142
    The 'Global and Chinese Urokinase Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Urokinase industry with a focus on the Chinese market. The report provides key statistics on the market status of the Urokinase manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, application......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs